Price
No data yet.
Social Signal Score
Analyst Ratings
25 analystsRevenue
$895.31M+27.38%Analyst Estimates
Consensus estimates, not results. Via Financial Modeling Prep.
Company Profile
- CEO
- Debra K. Osteen
- Sector
- Healthcare
- Industry
- Medical - Care Facilities
- Employees
- 22,000
- Beta
- 0.63
- Country
- US
- Piotroski score
- 4 / 9 (Middling)
- Altman Z-score
- 0.65
Financials
Revenue
$895.31M+27.4%Net Income
$34.49M-17.5%EBITDA
$146.88M+3.3%Free Cash Flow
$47.14M+6.4%EPS (diluted)
$0.38-20.8%Shares Outstanding (diluted)
91.75M+5.6%Operating Expenses
$58.66MCash & Debt
$163.31MReturn of Capital
$0.00Revenue by Segment (annual)
$3.31BQuote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $3.31B | $-1.10B | $-12.16 |
| 2024 | $3.15B | $255.61M | $2.79 |
| 2023 | $2.93B | $-21.67M | $-0.24 |
| 2022 | $2.61B | $273.14M | $3.05 |
| 2021 | $2.31B | $190.63M | $2.15 |
| 2020 | $2.09B | $-672.13M | $-7.65 |
| 2019 | $2.01B | $108.92M | $1.24 |
| 2018 | $3.01B | $-175.75M | $-2.01 |
| 2017 | $2.84B | $199.84M | $2.30 |
| 2016 | $2.81B | $6.14M | $0.07 |
| 2015 | $1.79B | $119.55M | $1.75 |
| 2014 | $1.00B | $83.04M | $1.51 |
| 2013 | $713.41M | $42.58M | $0.85 |
| 2012 | $407.46M | $20.40M | $0.53 |
Valuation
ACHChas no positive reported earnings per share, so an earnings-multiple projection can't be built for it. Companies are valued on other measures at this stage — revenue growth, cash burn, or book value — none of which this calculator models.
Signal Score (90d)
70+55.56%Social Signal Score
Mentions (20)
- Newszacks.com·12d ago·Positive
What Makes Acadia Healthcare (ACHC) a Strong Momentum Stock: Buy Now? Does Acadia Healthcare (ACHC) have what it takes to be a top stock pick for momentum investors? Let's find out.
View source ↗ - Newsseekingalpha.com·13d ago·Positive
Acadia Healthcare Company, Inc. (ACHC) Presents at 2026 UBS Global Healthcare Conference Transcript Acadia Healthcare Company, Inc. ( ACHC ) 2026 UBS Global Healthcare Conference November 9, 2026 11:00 AM EST Company Participants Debra Osteen - CEO & Director David Duckworth - Interim Chief Financial Officer Conference Call Participants Albert Rice - UBS Investment Bank, Research Division Presentation Albert Rice UBS Investment Bank, Research Division Hello, everyone. Thanks for joining us for o…
View source ↗ - Newsseekingalpha.com·15d ago·Positive
Acadia Healthcare Company, Inc. (ACHC) Q3 2026 Earnings Call Transcript Acadia Healthcare Company, Inc. ( ACHC ) Q3 2026 Earnings Call November 5, 2026 9:00 AM EST Company Participants Jason Plagman - Vice President of Investor Relations Debra Osteen - CEO & Director David Duckworth - Interim Chief Financial Officer Conference Call Participants Albert Rice - UBS Investment Bank, Research Division Benjamin Hendrix - RBC Capital Markets, Research Division Brian Tanquilut - Jefferies LLC, Research …
View source ↗ - Newszacks.com·16d ago·Positive
Acadia Healthcare Company, Inc. (ACHC) Hit a 52 Week High, Can the Run Continue? Acadia Healthcare (ACHC) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
View source ↗ - Newsmarketbeat.com·17d ago·Positive
Acadia Healthcare Q3 Earnings Call Highlights Acadia Healthcare NASDAQ: ACHC raised its full-year 2026 financial guidance for the third consecutive quarter after reporting third-quarter revenue growth and stronger-than-expected adjusted earnings, executives said on the company's earnings call.
View source ↗ - Newszacks.com·18d ago·Positive
Acadia Healthcare (ACHC) Surpasses Q3 Earnings and Revenue Estimates Acadia Healthcare (ACHC) came out with quarterly earnings of $0.6 per share, beating the Zacks Consensus Estimate of $0.46 per share. This compares to earnings of $0.72 per share a year ago.
View source ↗ - Newsbusinesswire.com·20d ago·Neutral
Acadia Healthcare to Participate in November Investor Conferences FRANKLIN, Tenn.--(BUSINESS WIRE)--Acadia Healthcare Company, Inc. (NASDAQ: ACHC) today announced that the Company will participate in two investor conferences in November. On Monday, November 9, 2026, the Company will participate in the 2026 UBS Global Healthcare Conference. The Company's presentation will begin at 11:00 a.m. Eastern Time/10:00 a.m. Central Time. On Wednesday, November 18, 2026, the Company will participate in the…
View source ↗ - Newszacks.com·45d ago·Neutral
Will Acadia Healthcare (ACHC) Beat Estimates Again in Its Next Earnings Report? Acadia Healthcare (ACHC) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
View source ↗ - Newszacks.com·48d ago·Positive
Acadia Healthcare (ACHC) Upgraded to Buy: Here's What You Should Know Acadia Healthcare (ACHC) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
View source ↗ - Newszacks.com·48d ago·Neutral
Is Acadia Healthcare (ACHC) Outperforming Other Medical Stocks This Year? Here is how Acadia Healthcare (ACHC) and Brookdale Senior Living (BKD) have performed compared to their sector so far this year.
View source ↗ - Newsbusinesswire.com·58d ago·Neutral
…hcare Provides Notice of Proposed Derivative Action Settlement FRANKLIN, Tenn.--(BUSINESS WIRE)--Acadia Healthcare Company, Inc. (“Acadia” or the “Company”) (NASDAQ: ACHC) issues the below summary notice of proposed settlement as provided for in the September 1, 2026 order providing preliminary approval issued by the United States District Court for the Middle District of Tennessee. UNITED STATES DISTRICT COURT MIDDLE DISTRICT OF TENNESSEE NASHVILLE DIVISION IN RE ACADIA HEALTHCARE COMPANY, INC.…
View source ↗ - Newsbenzinga.com·58d ago·Positive
Squeeze Watch: 10 Stocks With Over 33% Short Interest Ten stocks worth more than $2 billion each have more than a third of their float sold short. At the top of the list, one company has more than 80% of its float sold short.
View source ↗ - Newszacks.com·61d ago·Positive
Acadia Healthcare Jumps 100% YTD on Improving Outlook and Expansion ACHC shares have doubled YTD as a raised 2026 outlook, stronger cash flow and new facility openings bolster its rebound.
View source ↗ - Newszacks.com·61d ago·Positive
How Acadia Healthcare Is Turning Capacity Growth Into Cash Flow ACHC is converting capacity expansion into stronger cash flow as new facilities mature, patient volumes rise and capital spending stays disciplined.
View source ↗ - Newszacks.com·66d ago·Neutral
Zacks Industry Outlook Tenet, Acadia and Community Health Systems Tenet, Acadia and Community Health Systems have been highlighted in this Industry Outlook article.
View source ↗ - Newszacks.com·67d ago·Positive
3 Hospital Stocks Riding Strong Demand and Improved Efficiency The Zacks Medical-Hospital operators are benefiting from steady care demand while sharpening efficiency and portfolio strategy. Investors may want to track THC, ACHC and CYH.
View source ↗ - Newsbenzinga.com·69d ago·Neutral
These 10 Stocks Are Squeeze Candidates Waiting to Happen Short sellers are making bold bets, and the numbers behind those bets are getting harder to ignore. Pessimism this concentrated can set the stage for sharp reversals, since a heavily shorted stock only needs a piece of good news to send bears scrambling to cover their positions.
View source ↗ - Newsseekingalpha.com·91d ago·Negative
Acadia Healthcare Company Isn't Great, But The Big Picture Justifies Optimism Acadia Healthcare Company is a leading pure-play behavioral healthcare provider with 279 facilities and a growing patient base. ACHC's revenue continues to climb, but profitability is pressured by rising labor costs and a tight labor market. Despite higher net leverage and volatile cash flows, shares appear attractively priced on an absolute basis.
View source ↗ - Newsseekingalpha.com·95d ago·Positive
Acadia Healthcare Company: Capacity Expansion Adds To Growth Acadia Healthcare is rated BUY, driven by a robust capacity expansion pipeline and strong macro demand for mental health services. ACHC's defensible moat stems from its scale—279 facilities, 12.6k beds—positioning it as the largest independent U.S. behavioral healthcare provider. Forward EV/EBITDA of 8.8x reflects a 30% discount to the sector median and 17% below its five-year average, supporting valuation upside.
View source ↗ - Newszacks.com·100d ago·Neutral
Should You Continue to Hold ACHC Stock at an 18.17X P/E Valuation? ACHC's premium valuation faces a key test as facility growth and stronger EBITDA guidance compete with rising costs and weaker returns.
View source ↗
Earnings
Wed, Feb 24(in 3 months)
Consensus estimate $0.38 per share
Typical surprise +16.9% (median, so one quarter with a near-zero estimate can't distort it)
- Wed, Nov 4$0.60 vs $0.46beat
- Tue, Jul 28$0.38 vs $0.35beat
- Wed, Apr 29$0.37 vs $0.28beat
- Wed, Feb 25$0.07 vs $0.03beat
- Wed, Nov 5$0.72 vs $0.68beat
- Tue, Aug 5$0.83 vs $0.71beat
Estimates and results for ACHC via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.
Insider trading
Open-market buys and sells by ACHC officers and directors.
- Bought
- —
- Sold
- $3.7m
0 trades
4 trades
- Miquelon Wade Dsold
- Gregg Vicky Bsold
- Osteen Debra Ksold
- Osteen Debra Ksold
96 further Form 4 entries are share awards, option exercises or shares withheld for tax. Those are compensation, not trades, so they are excluded above. Buying is the stronger signal: an insider spends their own money for one reason. Selling has many innocent explanations — tax, diversifying, a house — so it says far less than it appears to. Via SEC filings.
Congress trades
- Susie Leehouse · NV03 · disclosed Dec 29, 2022 (29d later)Sell$1,001 - $15,000
- Peter Meijerhouse · MI03 · disclosed Mar 16, 2021 (28d later)Sell$1,001 - $15,000
Self-reported filings, amounts as brackets. Via Senate/House disclosures.
